Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Parkes

Showing results (41-50 of 189) with videos related to

Pageof 19
Sort By:
Nature Metabolism|September 25, 2025
A salute to innovation: exenatide in diabetes and obesity drug development at Amylin PharmaceuticalsJames L Trevaskis, David G Parkes, Andrew A Young
Peptides|May 5, 2001
Cardiovascular actions of CRH and urocortin: an updateD G Parkes, R S Weisinger, C N May
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 15, 1995
Beyond alcohol: beverage consumption and cardiovascular mortalityD M Goldberg, S E Hahn, J G Parkes
Life Sciences|January 1, 1995
Pyrogenic stimulation of vascular resistance in conscious sheepD G Parkes, J P Coghlan, B A Scoggins
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|July 1, 1995
Preferred room temperature of young vs aged males: the influence of thermal sensation, thermal comfort, and affectN A Taylor, N K Allsopp, D G Parkes
Environmental and Molecular Mutagenesis|January 1, 1990
Induction of prophage lambda by chlorophenolsD M DeMarini, H G Brooks, D G Parkes
Peptides|November 1, 1988
The effects of intracerebroventricular administration of biologically active peptides in conscious sheepD G Parkes, J P Coghlan, B A Scoggins
Toxicology|February 28, 1997
Characterization of Fe2+ and Fe3+ transport by iron-loaded cardiac myocytesJ G Parkes, N F Olivieri, D M Templeton
Regulatory Peptides|January 1, 2004
Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetesLoretta L Nielsen, Andrew A Young, David G Parkes
Life Sciences|January 1, 1989
Comparative hemodynamic actions of ANF-related peptides in conscious sheepD G Parkes, J P Coghlan, B A Scoggins
Pageof 19

Showing results (41-50 of 189) with videos related to

Sort By:
Pageof 19
Nature Metabolism|September 25, 2025
A salute to innovation: exenatide in diabetes and obesity drug development at Amylin PharmaceuticalsJames L Trevaskis, David G Parkes, Andrew A Young
Peptides|May 5, 2001
Cardiovascular actions of CRH and urocortin: an updateD G Parkes, R S Weisinger, C N May
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 15, 1995
Beyond alcohol: beverage consumption and cardiovascular mortalityD M Goldberg, S E Hahn, J G Parkes
Life Sciences|January 1, 1995
Pyrogenic stimulation of vascular resistance in conscious sheepD G Parkes, J P Coghlan, B A Scoggins
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|July 1, 1995
Preferred room temperature of young vs aged males: the influence of thermal sensation, thermal comfort, and affectN A Taylor, N K Allsopp, D G Parkes
Environmental and Molecular Mutagenesis|January 1, 1990
Induction of prophage lambda by chlorophenolsD M DeMarini, H G Brooks, D G Parkes
Peptides|November 1, 1988
The effects of intracerebroventricular administration of biologically active peptides in conscious sheepD G Parkes, J P Coghlan, B A Scoggins
Toxicology|February 28, 1997
Characterization of Fe2+ and Fe3+ transport by iron-loaded cardiac myocytesJ G Parkes, N F Olivieri, D M Templeton
Regulatory Peptides|January 1, 2004
Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetesLoretta L Nielsen, Andrew A Young, David G Parkes
Life Sciences|January 1, 1989
Comparative hemodynamic actions of ANF-related peptides in conscious sheepD G Parkes, J P Coghlan, B A Scoggins
Pageof 19